Compare ALLE & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLE | RVTY |
|---|---|---|
| Founded | 2013 | 1937 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 13.2B |
| IPO Year | N/A | N/A |
| Metric | ALLE | RVTY |
|---|---|---|
| Price | $167.34 | $103.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $170.33 | $110.38 |
| AVG Volume (30 Days) | 878.3K | ★ 1.6M |
| Earning Date | 02-18-2026 | 02-02-2026 |
| Dividend Yield | ★ 1.23% | 0.26% |
| EPS Growth | ★ 13.70 | N/A |
| EPS | ★ 7.39 | 2.07 |
| Revenue | ★ $3,979,700,000.00 | $2,856,051,000.00 |
| Revenue This Year | $10.07 | $4.69 |
| Revenue Next Year | $6.33 | $5.72 |
| P/E Ratio | ★ $22.40 | $52.05 |
| Revenue Growth | ★ 6.87 | 3.67 |
| 52 Week Low | $116.57 | $81.36 |
| 52 Week High | $180.68 | $126.57 |
| Indicator | ALLE | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 57.95 | 41.51 |
| Support Level | $162.42 | $101.70 |
| Resistance Level | $168.58 | $118.21 |
| Average True Range (ATR) | 3.14 | 4.06 |
| MACD | 0.12 | -1.38 |
| Stochastic Oscillator | 72.53 | 7.89 |
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.